Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

E-cigarette - E-vaporizers - ENDS - Vaping - Dabbing

5

III.m Coagulopathy

1
Last update : 25/06/2021
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Abused drugs/substances (illicit-, street drugs - IV/inhaled)
5
Cannabinoids - Cannabinoid receptor agonists (synthetic) (K2, Spice)
5
Diacetyl (2,3-butanedione) flavoring agent
3
E-cigarette's, e-vaporizer's secondhand vapor (Passive vaping)
1
Flavoring agents
5
Glue sniffing
3
Inhalants (volatile substances)
5
Marijuana, cannabis (haschish, hash, bang, dab)
5
Nicotine
1
Nitrous oxide (N2O)
1
Sildenafil
1
Tadalafil
1
Tetrahydrocannabinol (THC)
5
Tobacco smoke - Cigarette smoking
5
Vitamin E acetate (vaped, inhaled)
5

Publications

Clinical Findings in Adolescents Hospitalized With EVALI; Novel Report on Coagulopathy.
Hospital pediatrics 2022 Feb 01;12;229-240 2022 Feb 01
An improved method of determining free and acetylated polyamines by HPLC involving an enzyme reactor and an electrochemical detector.
Journal of biochemistry 1994 Mar;115;584-9 1994 Mar

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies